NDAINHALATIONGAS
Approved
Aug 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 5h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OXYGEN, USP (OXYGEN/NITROGEN 25/75) is a medical gas mixture delivered by inhalation for therapeutic use. This is a basic respiratory support product with a simple fixed-ratio composition. The drug addresses fundamental physiological needs in patients requiring oxygen supplementation.
Peak
Product is in peak lifecycle stage with moderate competitive pressure (30), suggesting stable demand but limited growth trajectory for commercial teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This product offers limited career growth potential given zero linked job openings and peak lifecycle stage. Roles are primarily in operations, regulatory compliance, and clinical support rather than high-visibility commercial or R&D positions.
Respiratory Care SpecialistClinical Operations
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.